$BSTCE BIOSPECIFICS TECHNOLOGIES CORP Insider Trading
Get free email notifications about insider trading in BIOSPECIFICS TECHNOLOGIES CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIOSPECIFICS TECHNOLOGIES CORP. Insider overview, share value development, latest insider transactions and email notifications about new events in BIOSPECIFICS TECHNOLOGIES CORP for free.
CIK Number: 0000875622
IRS Number: 113054851
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: BSTCE
Company Address: 35 WILBUR ST LYNBROOK 11563
Prev close: $0.00
Average Daily Volume: 0
Days Low: $0.00
Year Low: $0.00
Year High: $0.00
BIOSPECIFICS TECHNOLOGIES CORP Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 02 2020 | BSTCE | BIOSPECIFICS TECHN ... | HUTCHISON PATRICK | Chief Financial Off ... | Option Exercise | D | 56.21 | 10,000 | 562,100 | 0 | |
Dec 02 2020 | BSTCE | BIOSPECIFICS TECHN ... | Sherman Michael A. | Director | Option Exercise | D | 55.63 | 6,000 | 333,780 | 0 | |
Dec 02 2020 | BSTCE | BIOSPECIFICS TECHN ... | HUTCHISON PATRICK | Chief Financial Off ... | Option Exercise | D | 56.21 | 10,000 | 562,100 | 0 | |
Dec 02 2020 | BSTCE | BIOSPECIFICS TECHN ... | Sherman Michael A. | Director | Sell | D | 0.00 | 2,018 | 0 | 0 | 2 K to 0 (-100.00 %) |
Dec 02 2020 | BSTCE | BIOSPECIFICS TECHN ... | Sherman Michael A. | Director | Option Exercise | D | 55.63 | 6,000 | 333,780 | 0 | |
Dec 02 2020 | BSTCE | BIOSPECIFICS TECHN ... | Sherman Michael A. | Director | Sell | D | 0.00 | 2,018 | 0 | 0 | 2 K to 0 (-100.00 %) |
Jul 17 2020 | BSTCE | BIOSPECIFICS TECHN ... | Gitman Paul | Director | Grant | A | 0.00 | 1,726 | 0 | 18,616 | 16.9 K to 18.6 K (+10.22 %) |
Jul 17 2020 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Grant | A | 0.00 | 1,726 | 0 | 3,616 | 1.9 K to 3.6 K (+91.32 %) |
Jul 17 2020 | BSTCE | BIOSPECIFICS TECHN ... | Chao Jennifer M | Director | Grant | A | 0.00 | 1,726 | 0 | 3,646 | 1.9 K to 3.6 K (+89.90 %) |
Jul 17 2020 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Mark N | Director | Grant | A | 0.00 | 1,726 | 0 | 68,888 | 67.2 K to 68.9 K (+2.57 %) |
Jul 17 2020 | BSTCE | BIOSPECIFICS TECHN ... | Schamroth Michael | Director | Grant | A | 0.00 | 1,726 | 0 | 117,616 | 115.9 K to 117.6 K (+1.49 %) |
May 29 2020 | BSTCE | BIOSPECIFICS TECHN ... | Truitt Joseph | Chief Executive Off ... | Option Exercise | A | 63.72 | 130,000 | 8,283,600 | 130,000 | |
May 04 2020 | BSTCE | BIOSPECIFICS TECHN ... | Fishman Corey N. | Director | Option Exercise | A | 55.63 | 6,000 | 333,780 | 6,000 | |
May 04 2020 | BSTCE | BIOSPECIFICS TECHN ... | Sherman Michael A. | Director | Option Exercise | A | 55.63 | 6,000 | 333,780 | 6,000 | |
Apr 15 2020 | BSTCE | BIOSPECIFICS TECHN ... | Fishman Corey N. | Director | Grant | A | 0.00 | 2,018 | 0 | 2,018 | 0 to 2 K |
View all BIOSPECIFICS TECHNOLOGIES CORP insider transactions.